PaLM Conf Minutes 2022-January-12

From IHE Wiki
Jump to navigation Jump to search

Attendees

Name Email
Alessandro Sulis alessandro.sulis@crs4.it
Jim McNulty jmcnult@cap.org
Mary Kennedy mkenned@cap.org
Dan Rutz drutz@epic.com
Raj Dash r.dash@duke.edu
David DeMena
Jim Harrison james.harrison@virginia.edu
Francesca Frexia francesca.frexia@crs4.it
JD Nolen jdlnolen@gmail.com
Gianluca Pavan Arsenal.IT
Gunter Haroske haroske@icloud.com
Filip Migom filip.migom@gmail.com
Nick Haarselhorst nick.haarselhorst@philips.com
Kevin Schap kschap@cap.org
Megumi Kondo megumi.kondo.sakura.japan@gmail.com
Jurgen Brandstatter j.brandstaetter@codewerk.at
Hynek Kruzik kruzik@gnomon.cz
Francois Macary Francois.macary@phast.fr
Riki Merrick rikimerrick@gmail.com


Next meeting: February 9, 2022


  • Administration:
    • F2F: The group will stick with the dates currently scheduled, 5/2-5/4, 2022
    • Wiki changes needed:
      • Milestones for 2021 and 2022 need to do this before the IHE PaLM Board report is finalized this week.
      • Dates are needed for the publication matrix for 2022.
      • As a group, we should make sure EVERY published profile has a wiki page using the correct template
    • IHE PaLM Board report:
      • Alessandro will check on participation numbers for Connectathon participation in 2021.
      • The tables will be combined into the first table.
      • Riki will send a draft to the email list - please provide feedback by the end of this week.
  • DP-AT project update
    • The white paper will be sent out by email to provide feedback. Please send feedback by the next PaLM committee call
    • Please share the document as a pdf and send comments back to Gianluca
    • The challenge of vendors receiving DP-AT because of PACs system drive workflow was discussed.
  • HL7 Germany
    • DEMIS FHIR specs are the official spec for reporting micro to PH starting tomorrow.
    • APSR work is separate from DEMIS FHIR
      • IHE PaLM Image1 01-12-2022.jpg
      • Link to the current draft: https://simplifier.net/medizininformatikinitiative-modulpathologie
      • There is work creating the Diagnostic Report section.
      • Diagnostic Conclusion will be a very short observation in the report.
      • Group observations to cover the grouping into the CDA sections were created, and then those have all the observations.
      • A bundle was created and used composition to support the document. The document will have IG available for the ballot at HL7 Germany in March
    • Are there plans to coordinate with SDC for structured data?
      • Yes, those structured data are in the individual observations
    • Creating a logical model in eXHealth
      • Gunter is also the primary author of APSR 2.1 in art décor. He can help support the eXHealth effort, too
      • These two efforts might fit together well.
      • It was requested that Gunter attends the Tuesday morning meetings.
    • OO also came up with the solution of combining composition with DiagnosticReport
      • The two approaches should be compared to ensure we can resolve any differences (also include the genomics reporting)
        • In Germany, genomics doesn't use composition but does build a similar diagnostic report.
        • It should be determined to find a project to make this comparison soon:
        • The PH (Helios) and genomics accelerators at HL7 may be the best home for this.
        • JD will add awareness for the genomics quarter next week.
        • However, we may need a separate project
  • Xe-health
    • Two variant options to express the lab content?
      • 4/5 countries only using variant 1;
      • What was the reasoning for having two variants?
        • We allowed this to accommodate the various pdf printed reports - in France; we had two possible layouts:
        • French extension of XD-Lab is here: ADD LINK!!!
        • variant 1 = single chapter with all results
        • variant two = only organizes the narrative blocks by creating a high-level section (Laboratory Speciality section) with subsections (laboratory Report Item)
          • The issue is that the example uses a code for a single lab test in the subsection rather than a subsection code, causing some confusion
    • It may be worth revising the examples to make it clearer to use a section code here instead.
    • The next step is for Juergen to write the CP.
  • The list of LOINC section codes will need to be updated
    • It must be understood that these are example codes and not a complete list.
    • ArtDecor implemented this as SHALL.
    • Do we also want to allow other code systems?
    • SHOULD can have two value set bindings
      • Extensible = must be LOINC but can add more codes
      • Preferred = could be this or any other code system
    • We need to increase the content and make the value set extensible.
    • This does not need to track the type of laboratory that created these results, so rename the section to Lab test type rather than lab specialty
    • The next step is for Juergen to write the CP to make the value set extensible and change the name from Specialty to Study Type. Juergen will write the CP
    • Juergen will have Francois and some others review the above CPs
  • Status codes:
    • There are three levels:
      • Status of observation:
        • There is a need for at least: preliminary, completed, aborted, corrected
        • XD-lab is intended to support ONLY the communications when the workflow is complete, so preliminary is not needed in that case.
        • The group should think about correcting and entered-in-error.
          • Entered-in-error:
            • It seems to be more of an annotation on the electronic record in the dB.
          • The laboratory should be able to reconstruct the history of everything that has been shared, but it is not easy on the consumer side to do with this.
          • Corrected:
            • What if you send results in different formats? How do you track corrections across various means, and what status should be assigned to each.
      • Status of order:
        • We didn't discuss this.
        • For V2, we have a matrix of order status based on observation status
          • From LRI:
          • IHE PaLM Image2 01-12-2022.jpg
          • In IHE Pathology & Laboratory Medicine Technical Framework, Vol. 2x (PaLM TF-2x): C.10 Correlations of Status between ORC, OBR, OBX
      • Status of document:
        • It should not be computed from the status of the observations.
      • Juergen will share the discussion around this document
      • Riki will share minutes from Lab calls (Fridays 1 – 2 PM ET on OO meeting coordinates) when we are discussing statuses - in general, meeting notes are here – Click on LAB: https://confluence.hl7.org/display/OO/OO+Meeting+Minutes
      • Using CDA for workflow?
        • CDA is expected to be a snapshot of the data at a specific point in time; CDA can point to the previous report that this report replaces
        • CDA is not made to handle workflows - IHE created XDW to address some of these issues.
        • France will create a CDA to document orders to a data repository, but not for actual order workflow handling.
        • Cross-border e-prescription use is acceptable because you share a persisted prescription document (think of it as a copy) of only those who still have open prescriptions.
        • They are updated by providing a new version, but the dispensing status is not part of that new version.
  • We will continue the next IHE PaLM call on Feb 9